Artiva Biotherapeutics, Inc.
ARTV
$10.79
-$0.09-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 349.39M | 86.78M | 108.01M | 122.97M | 142.37M |
| Total Receivables | 1.44M | 600.00K | 767.00K | 879.00K | 1.03M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.44M | 1.36M | 3.89M | 5.68M | 5.67M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 352.28M | 88.74M | 112.67M | 129.52M | 149.07M |
|
|
|||||
| Total Current Assets | 352.28M | 88.74M | 112.67M | 129.52M | 149.07M |
| Net Property, Plant & Equipment | 15.09M | 16.30M | 17.36M | 18.46M | 19.83M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.27M | 919.00K | 919.00K | 879.00K | 499.00K |
| Total Assets | 368.63M | 105.96M | 130.94M | 148.86M | 169.39M |
|
|
|||||
| Total Accounts Payable | 1.39M | 2.29M | 355.00K | 848.00K | 1.22M |
| Total Accrued Expenses | 9.90M | 5.56M | 9.60M | 7.03M | 5.84M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.30M | 3.04M | 3.06M | 3.17M | 3.64M |
| Total Finance Division Other Current Liabilities | -- | -- | 73.00K | 73.00K | 73.00K |
| Total Other Current Liabilities | -- | -- | 73.00K | 73.00K | 73.00K |
| Total Current Liabilities | 14.58M | 10.88M | 13.09M | 11.12M | 10.77M |
|
|
|||||
| Total Current Liabilities | 14.58M | 10.88M | 13.09M | 11.12M | 10.77M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 6.55M | 7.23M | 7.88M | 8.52M | 9.58M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 21.13M | 18.11M | 20.97M | 19.64M | 20.35M |
|
|
|||||
| Common Stock & APIC | 726.59M | 441.93M | 440.42M | 438.91M | 437.29M |
| Retained Earnings | -379.07M | -354.07M | -330.55M | -309.78M | -288.25M |
| Treasury Stock & Other | -21.00K | -18.00K | 103.00K | 87.00K | 2.00K |
| Total Common Equity | 347.50M | 87.85M | 109.97M | 129.22M | 149.04M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 347.50M | 87.85M | 109.97M | 129.22M | 149.04M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 347.50M | 87.85M | 109.97M | 129.22M | 149.04M |
|
|
|||||